The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing the sixth leading cause of cancer and the third leading cause of cancer-related mortality. Patient stratification and treatment allocation are based on tumor stage, liver function, and performance status. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line treatment for patients with intermediate stage HCC, including those with large or multinodular HCC, well-preserved liver function, and no cancer-related symptoms or evidence of vascular invasion or extrahepatic spread. Two TACE techniques have been used since 2004, conventional TACE (cTACE) and TACE with drug-eluting beads (DEB-TACE). cTACE was evidenced first to treat intermediate stage HCC patients. It combines the transcatheter delivery of chemotherapy using Lipiodol-based emulsion plus an embolizing agent to achieve strong cytotoxic and ischemic effects. Drug-eluting beads (DEBs) were developed in order to slowly release chemotherapeutic agents, and to increase ischemia intensity and duration. Recent advances allow TACE treatment of both early stage patients (i.e. those with a solitary nodule or up to 3 nodules under 3 cm) and some advanced stage patients. Here we review recent clinical evidence related to TACE treatment of patients with early, intermediate, and advanced stage HCC. Based on the 2014 TACE algorithm of Raoul et al., this international expert panel proposes an updated TACE algorithm and provides insights into TACE use for patients at any HCC stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationSorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Self-citationKudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Lencioni, R., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247132 · Cited by 4,329
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K., Meyer, T., Cheng, A.-L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y., Park, J.-W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717002 · Cited by 2,344
Self-citationLammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Varela, M., Real, M. I., Burrel, M., Forner, A., Sala, M., Brunet, M., Ayuso, C., Castells, L., Montañá, X., Llovet, J. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.020 · Cited by 941
Self-citationGlobal Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Zhu, A. X., Park, J. O., Ryoo, B.-Y., Yen, C.-J., Poon, R., Pastorelli, D., Blanc, J.-F., Chung, H. C., Baron, A. D., Pfiffer, T. E. F., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00050-9 · Cited by 846
Lencioni, R., de Baere, T., Soulen, M. C., Rilling, W. S., & Geschwind, J. H. (2016) · Hepatology · doi:10.1002/hep.28453 · Cited by 732
Self-citationYau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Lencioni, R., Llovet, J. M., Han, G., Tak, W. Y., Yang, J., Guglielmi, A., Paik, S. W., Reig, M., Kim, D. Y., Chau, G.-Y., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.012 · Cited by 694
Burroughs, A., Dufour, J.-F., Galle, P., Mazzaferro, V., Piscaglia, F., Raoul, J., Sangro, B., & Bolondi, L. (2013) · Seminars in Liver Disease · doi:10.1055/s-0032-1329906 · Cited by 641
Self-citationon behalf of the PRECISION ITALIA STUDY GROUP, Golfieri, R., Giampalma, E., Renzulli, M., Cioni, R., Bargellini, I., Bartolozzi, C., Breatta, A. D., Gandini, G., Nani, R., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.199 · Cited by 606
Self-citationRaoul, J.-L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.006 · Cited by 537
Self-citationPeng, Z.-W., Zhang, Y.-J., Chen, M.-S., Xu, L., Liang, H.-H., Lin, X.-J., Guo, R.-P., Zhang, Y.-Q., & Lau, W. Y. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9936 · Cited by 531
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M. W., Sturgess, R., Stubbs, C., Stocken, D. D., Wall, L., Watkinson, A., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30156-5 · Cited by 499
Burrel, M., Reig, M., Forner, A., Barrufet, M., Lope, C. R. D., Tremosini, S., Ayuso, C., Llovet, J. M., Real, M. I., & Bruix, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.008 · Cited by 485
Self-citationCho, Y. K., Kim, J. K., Kim, M. Y., Rhim, H., & Han, J. K. (2009) · Hepatology · doi:10.1002/hep.22648 · Cited by 466
Treatment of intermediate-stage hepatocellular carcinoma
Forner, A., Gilabert, M., Bruix, J., & Raoul, J.-L. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.122 · Cited by 466
Self-citationN'Kontchou, G., Mahamoudi, A., Aout, M., Ganne-Carrié, N., Grando, V., Coderc, E., Vicaut, E., Trinchet, J. C., Sellier, N., Beaugrand, M., et al. (2009) · Hepatology · doi:10.1002/hep.23181 · Cited by 450
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Petrick, J. L., Kelly, S. P., Altekruse, S. F., McGlynn, K. A., & Rosenberg, P. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7412 · Cited by 442
Forner, A., Ayuso, C., Varela, M., Rimola, J., Hessheimer, A. J., de Lope, C. R., Reig, M., Bianchi, L., Llovet, J. M., & Bruix, J. (2009) · Cancer · doi:10.1002/cncr.24050 · Cited by 426
Self-citationKokudo, N., Hasegawa, K., Akahane, M., Igaki, H., Izumi, N., Ichida, T., Uemoto, S., Kaneko, S., Kawasaki, S., Ku, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12464 · Cited by 391
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., Hackshaw, A., Fox, R., Johnson, P., Burroughs, A. K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt247 · Cited by 370
Kudo, M., Han, G., Finn, R. S., Poon, R. T. P., Blanc, J.-F., Yan, L., Yang, J., Lu, L., Tak, W.-Y., Yu, X., et al. (2014) · Hepatology · doi:10.1002/hep.27290 · Cited by 355
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M., & Peck-Radosavljevic, M. (2013) · Hepatology · doi:10.1002/hep.26256 · Cited by 343
Luo, J., Guo, R.-P., Lai, E. C. H., Zhang, Y.-J., Lau, W. Y., Chen, M.-S., & Shi, M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1321-8 · Cited by 328
Bolondi, L., Burroughs, A. K., Dufour, J.-F., Galle, P. R., Mazzaferro, V., Piscaglia, F., Raoul, J., & Sangro, B. (2012) · BORIS (University Library Bern) · Cited by 320
Self-citationLau, W. Y., & Lai, E. C. H. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31818eec29 · Cited by 304
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion
de Baere, T., Arai, Y., Lencioni, R., Geschwind, J.-F., Rilling, W., Salem, R., Matsui, O., & Soulen, M. C. (2016) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-015-1208-y · Cited by 272
Self-citationGolfieri, R., Cappelli, A., Cucchetti, A., Piscaglia, F., Carpenzano, M., Peri, E., Ravaioli, M., D'Errico-Grigioni, A., Pinna, A. D., & Bolondi, L. (2011) · Hepatology · doi:10.1002/hep.24246 · Cited by 264
Self-citationMillonig, G., Graziadei, I. W., Freund, M. C., Jaschke, W. R., Stadlmann, S., Ladurner, R., Margreiter, R., & Vogel, W. (2007) · Liver Transplantation · doi:10.1002/lt.21033 · Cited by 257
International incidence and mortality trends of liver cancer: a global profile
Wong, M. C. S., Jiang, J. Y., Goggins, W. B., Liang, M., Fang, Y., Fung, F. D. H., Leung, C., Wang, H. H. X., Wong, G. L. H., Wong, V. W. S., et al. (2017) · Scientific Reports · doi:10.1038/srep45846 · Cited by 255
Shim, J. H., Lee, H. C., Kim, S.-O., Shin, Y. M., Kim, K. M., Lim, Y.-S., & Suh, D. J. (2012) · Radiology · doi:10.1148/radiol.11110282 · Cited by 251
Takayasu, K., Arii, S., Kudo, M., Ichida, T., Matsui, O., Izumi, N., Matsuyama, Y., Sakamoto, M., Nakashima, O., Ku, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.021 · Cited by 214
Facciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.02.005 · Cited by 209
Malagari, K., Pomoni, M., Moschouris, H., Bouma, E., Koskinas, J., Stefaniotou, A., Marinis, A., Kelekis, A., Alexopoulou, E., Chatziioannou, A., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0394-0 · Cited by 208
Hsu, C.-Y., Lee, Y.-H., Hsia, C.-Y., Huang, Y.-H., Su, C.-W., Lin, H.-C., Lee, R.-C., Chiou, Y.-Y., Lee, F.-Y., & Huo, T.-I. (2013) · Hepatology · doi:10.1002/hep.25950 · Cited by 205
Kudo, M., Cheng, A.-L., Park, J.-W., Park, J. H., Liang, P.-C., Hidaka, H., Izumi, N., Heo, J., Lee, Y. J., Sheen, I.-S., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30290-x · Cited by 199
Guiu, B., Deschamps, F., Aho, S., Munck, F., Dromain, C., Boige, V., Malka, D., Leboulleux, S., Ducreux, M., Schlumberger, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.012 · Cited by 191
Self-citationNamur, J., Citron, S. J., Sellers, M. T., Dupuis, M. H., Wassef, M., Manfait, M., & Laurent, A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.024 · Cited by 177
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Adhoute, X., Penaranda, G., Naude, S., Raoul, J. L., Perrier, H., Bayle, O., Monnet, O., Beaurain, P., Bazin, C., Pol, B., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.014 · Cited by 171
Self-citationHucke, F., Pinter, M., Graziadei, I., Bota, S., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., Peck-Radosavljevic, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.002 · Cited by 159
Xue, T., Xie, X., Zhang, L., Yin, X. H., Zhang, B., & Ren, Z. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-60 · Cited by 156
Ronot, M., Bouattour, M., Wassermann, J., Bruno, O., Dreyer, C., Larroque, B., Castéra, L., Vilgrain, V., Belghiti, J., Raymond, É., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0114 · Cited by 156
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
Terzi, E., Golfieri, R., Piscaglia, F., Galassi, M., Dazzi, A., Leoni, S., Giampalma, E., Renzulli, M., & Bolondi, L. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.025 · Cited by 154
Self-citationHow to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
Raoul, J., Gilabert, M., & Piana, G. (2014) · Liver Cancer · doi:10.1159/000343867 · Cited by 150
Self-citationde Luna, W., Sze, D. Y., Ahmed, A., Ha, B., Ayoub, W. S., Keeffe, E. B., Cooper, A. D., Esquivel, C. O., & Nguyen, M. H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02576.x · Cited by 143
Kloeckner, R., Weinmann, A., Prinz, F., dos Santos, D. P., Ruckes, C., Dueber, C., & Pitton, M. B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1480-x · Cited by 136
Self-citationPompili, M., Francica, G., Ponziani, F. R., Iezzi, R., & Avolio, A. W. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7515 · Cited by 128
Geschwind, J.-F. H., Kudo, M., Marrero, J. A., Venook, A. P., Chen, X., Bronowicki, J., Dagher, L., Furuse, J., de Guevara, L. L., Papandreou, C. N., et al. (2016) · Radiology · doi:10.1148/radiol.2015150667 · Cited by 120
Monier, A., Guiu, B., Durán, R., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4488-y · Cited by 107
Kim, D. Y., Ryu, H. J., Choi, J., Park, J. Y., Lee, D. Y., Kim, B. K., Kim, S. U., Ahn, S. H., Chon, C. Y., & Han, K. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05089.x · Cited by 93
Chan, S. L., Mo, F. K. F., Johnson, P. J., Liem, G. S., Chan, T. C., Poon, M. C., Ma, B. B. Y., Leung, T. W. T., Lai, P. B. S., Chan, A. T. �., et al. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06329.x · Cited by 90
Waked, I. A., Berhane, S., Toyoda, H., Chan, S. L., Stern, N., Palmer, D. H., Tada, T., Yeo, W., Mo, F. K. F., Bettinger, D., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.423 · Cited by 84
Spreafico, C., Cascella, T., Facciorusso, A., Sposito, C., Lanocita, R., Morosi, C., Civelli, E. M., Vaiani, M., Bhoori, S., Pellegrinelli, A., et al. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0907-0 · Cited by 75
Terzi, E., Terenzi, L., Venerandi, L., et al. (2014) · Digestive Diseases · doi:10.1159/000368007 · Cited by 63
Kudo, M., & Arizumi, T. (2017) · Oncology · doi:10.1159/000481243 · Cited by 61
Cucchetti, A., Trevisani, F., Cappelli, A., Mosconi, C., Renzulli, M., Pinna, A. D., & Golfieri, R. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.03.031 · Cited by 58
Bonekamp, S., Li, Z., Geschwind, J.-F. H., Halappa, V. G., Corona‐Villalobos, C. P., Reyes, D. K., Pawlik, T. M., Bonekamp, D., Eng, J., & Kamel, I. R. (2013) · Radiology · doi:10.1148/radiol.13122307 · Cited by 42
Repeated transarterial chemoembolization: An overfitting effort?
Facciorusso, A., Bhoori, S., Sposito, C., & Mazzaferro, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.033 · Cited by 20
Cited by
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Self-citationLocoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, J. M., De Baere, T., Kulik, L., Haber, P. K., Greten, T. F., Meyer, T., & Lencioni, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00395-0 · Cited by 1,044
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Llovet, J. M., Pinyol, R., Kelley, R. K., El-Khoueiry, A., Reeves, H. L., Wang, X. W., Gores, G. J., & Villanueva, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00357-2 · Cited by 498
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 341
Metadata
- Authors
- Raoul, J.-L., Forner, A., Bolondi, L., Cheung, T. T., Kloeckner, R., & de Baere, T.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 72
- Pages
- 28-36
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2900776966
- Cited by
- 643
- References
- 71
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.